Omicron XBB.1.5 monovalent booster vaccine

· Clover Biopharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Omicron XBB.1.5 monovalent booster vaccine, covering 2024-08-22 to 2024-08-22. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety Study of Monovalent Omicron XBB.1.5 Vaccine as a Booster in Adults [Phase 3]